0000000001307441

AUTHOR

Axel Haferkamp

showing 53 related works from this author

Multicenter analysis of serum tumor markers, treatment patterns, and relapse in patients with testicular cancer in clinical stage IS.

2020

5052 Background: Testicular germ cell tumors (TGCT) in clinical stage I (CSI) are tumors confined to the testis without evidence of metastasis. Around 50% of all TGCT patients present with elevated serum tumor markers (TM) such as alpha-feto protein (AFP), beta-humanochoriongonadotropin (ß-HCG) and lactate-dehydrogenase (LDH). After ablatio testis, TMs usually return to normal according to half-life kinetics, however, in clinical stage IS (CSIS) TMs remain elevated or increase after surgery. Follow-up data on CSIS is scarce and our study aims to assess clinical characteristics and oncologic outcomes in a large TGCT cohort. Methods: In this multicenter study we collected data from 5 tertiar…

OncologyCancer Researchmedicine.medical_specialtybusiness.industrymedicine.diseaseTesticular germ cellMetastasisOncologyInternal medicineMedicineIn patientStage (cooking)businessTesticular cancerJournal of Clinical Oncology
researchProduct

Trend analysis and regional tumor incidence in Germany for testicular cancer between 2003 and 2014

2019

BACKGROUND Testicular germ cell tumor (TGCT) is one the most common solid tumors in men between the age of 15 and 35 with an overall incidence rate of 1-1.5 %. Epidemiologic studies have demonstrated different incidence patterns in western civilized countries with overall rising incidence trends. OBJECTIVE To analyze differences in regional tumor incidence rates for TGCT and perform a trend analysis for TGCT between 2003 and 2014 in Germany. MATERIAL AND METHODS TGCT cases in Germany which were diagnosed between 2003 and 2014 were provided by the Robert-Koch-Institute, Berlin. For statistical analysis, cluster and spatial scan tests according to Kulldorff were used for cases with seminoma a…

AdultMaleOncologymedicine.medical_specialtyTumor incidenceAdolescentendocrine system diseasesUrologyEndocrinology Diabetes and MetabolismTesticular Germ Cell Tumorurologic and male genital diseasesYoung Adult03 medical and health sciences0302 clinical medicineEndocrinologyTesticular NeoplasmsGermanyStatistical significanceInternal medicineEpidemiologymedicineHumansChildTesticular cancerAgedAged 80 and over030219 obstetrics & reproductive medicinebusiness.industryIncidenceIncidence (epidemiology)SeminomaMiddle AgedNeoplasms Germ Cell and Embryonalmedicine.diseaseSeminomaTrend analysisReproductive MedicinebusinessAndrology
researchProduct

Abstract 1423: Shikonin impairs the growth of docetaxel-resistant prostate cancer cells by necroptosis

2021

Abstract Introduction: Prostate carcinoma (PCa) is the most common malignancy in men. Androgen-targeted therapy and chemotherapy are currently the treatment of choice for advanced stages. Due to resistance towards these therapies, prognosis remains poor and new treatment options are urgently required. Shikonin (SHI) from Traditional Chinese Medicine (TCM) might be promising, since it induces anti-tumor effects in different tumor entities. However, data on PCa are few, and data on resistant PCa are not existent. Material and Methods: Parental (=sensitive) and docetaxel-resistant PCa cell lines, PC3, DU145, LNCaP, and 22Rv1 were exposed to SHI [0.1 - 1.5 μM] for 24, 48, or 72 hours. Untreated…

Cancer ResearchCell cycle checkpointbusiness.industryNecroptosisCancerCell cycleurologic and male genital diseasesmedicine.diseaseProstate cancerOncologyDocetaxelDU145LNCaPCancer researchMedicinebusinessmedicine.drugCancer Research
researchProduct

Telemedicine Online Visits in Urology During the COVID-19 Pandemic-Potential, Risk Factors, and Patients' Perspective.

2020

The current coronavirus disease 2019 (COVID-19) pandemic has placed considerable strain on hospital resources. We explored whether telemedicine (defined as a videoconference) might help. We undertook prospective structured phone interviews of urological patients (n = 399). We evaluated their suitability for telemedicine (judged by a panel of four physicians) and their risks from COVID-19 (10 factors for a poor outcome), and collected willingness for telemedicine and demographic data. Risk factors for an adverse outcome from COVID-19 infection were common (94.5% had one or more) and most patients (63.2%) were judged suitable for telemedicine. When asked, 84.7% of patients wished for a teleme…

medicine.medical_specialtyTelemedicineUrologic NeoplasmsCoronavirus disease 2019 (COVID-19)UrologyPneumonia Viral030232 urology & nephrologyUrologySubgroup analysisTelehealthMedical Oncology03 medical and health sciencesBetacoronavirus0302 clinical medicineRisk FactorsPandemicOutpatientsDisease Transmission InfectiousMedicineHumansMedical diagnosisPandemicsRemote Consultationbusiness.industrySARS-CoV-2Remote ConsultationCOVID-19Odds ratioTelemedicine030220 oncology & carcinogenesisbusinessCoronavirus InfectionsEuropean urology
researchProduct

Characterization of PD-1 and PD-L1 Expression in Papillary Renal Cell Carcinoma: Results of a Large Multicenter Study

2021

Abstract Background Programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) play a decisive role as prognostic markers in clear-cell renal cell carcinoma (RCC). To date, the role of PD-1/PD-L1 as a prognostic marker in papillary RCC (pRCC) remains scarce. Patients and Methods Patients’ sample collection was a joint collaboration of the nationwide PANZAR consortium – a multicenter study. Medical history and tumor specimens were collected from 245 and 129 patients with pRCC types 1 and 2, respectively. Expression of PD-1 and PD-L1 was determined by immunohistochemistry in pRCC and tumor-infiltrating mononuclear cells. Results Of 374 pRCC specimens, 204 type 1 and 97 type 2 we…

Oncologymedicine.medical_specialtyUrologyProgrammed Cell Death 1 Receptor030232 urology & nephrology610DiseaseB7-H1 Antigen03 medical and health sciences0302 clinical medicineRenal cell carcinomaInternal medicinePD-L1Biomarkers TumormedicineHumansMedical historyCarcinoma Renal CellPapillary renal cell carcinomasbiologybusiness.industryPrognosismedicine.diseaseKidney NeoplasmsOncology030220 oncology & carcinogenesisCohortbiology.proteinImmunohistochemistrySample collectionbusinessClinical Genitourinary Cancer
researchProduct

Advantages and Disadvantages of Bone Protective Agents in Metastatic Prostate Cancer: Lessons Learned

2016

Nine out of ten metastatic prostate cancer (PCa) patients will develop osseous metastases. Of these, every second will suffer from skeletal-related events (SRE). SRE are associated with an increased risk for death, which is markedly increased in the presence of pathological fracture. Moreover, health insurance costs nearly double in the presence of SRE. Zoledronic acid and denosumab are both approved drugs for the prevention or delay of SRE in castration-resistant prostate cancer (CRPC) patients with osseous metastases. However, long-term treatment with one of these two drugs is associated with the development of medication-related osteonecrosis of the jaw (MRONJ). Routine inspections of th…

Oncologymedicine.medical_specialtyReview03 medical and health sciencesProstate cancerzoledronic acid0302 clinical medicineInternal medicinemedicineStage (cooking)General DentistryPathologicalmedicine.diagnostic_testbusiness.industryIncidence (epidemiology)osteonecrosisdenosumab030206 dentistrymedicine.diseaseprostate cancerSurgerylcsh:RK1-715Zoledronic acidDenosumabBone scintigraphy030220 oncology & carcinogenesislcsh:DentistrybusinessOsteonecrosis of the jawmedicine.drugDentistry Journal
researchProduct

Evaluation of TKTL1 as a biomarker in serum of prostate cancer patients.

2016

Introduction Monocyte associated transketolase-like 1 (TKTL1) as a cancer biomarker has become popular with alternative practitioners, but plays no role in conventional medicine. This investigation evaluates the potential of serum TKTL1 as a biomarker for prostate cancer. Material and methods Patients (n = 66) undergoing curative radical prostatectomy (RPE) for biopsy-pro-ven PCa were included in the study. Controls (n = 10) were healthy, age-matched, male volunteers. 10 ml of peripheral blood was drawn from patients several days before surgery and from controls. Serum TKTL1 was measured using the ELISA method. Results The median age at tumor diagnosis was 66 years and median serum PSA was …

Conventional medicineOncologymedicine.medical_specialtydiagnosismedicine.medical_treatmentTKTL102 engineering and technologyGastroenterology03 medical and health sciencesProstate cancer0302 clinical medicineInternal medicineTumor stagemedicinecomplementary medicineElisa methodOriginal PaperProstatectomybusiness.industryMonocyteGleason SumGeneral Medicine021001 nanoscience & nanotechnologymedicine.diseaseprostate cancerPeripheral bloodmedicine.anatomical_structure030220 oncology & carcinogenesisbiomarker0210 nano-technologybusinessCentral European journal of urology
researchProduct

The Use of Neoadjuvant Chemotherapy in Patients With Urothelial Carcinoma of the Bladder: Current Practice Among Clinicians.

2017

Abstract Introduction Guidelines recommend neoadjuvant chemotherapy (NAC) before radical cystectomy (RC) in patients with urothelial carcinoma of the bladder in clinical stages T2-T4a, cN0M0. We examined the frequency and current practice of NAC and sought to identify predictors for the use of NAC in a prospective contemporary cohort. Materials and Methods We analyzed prospective data from 679 patients in the PROMETRICS (PROspective MulticEnTer RadIcal Cystectomy Series 2011) database. All patients underwent RC in 2011. Uni- and multivariable regression analyses identified predictors of NAC application. Furthermore, a questionnaire was used to evaluate the practice patterns of NAC at the PR…

Malemedicine.medical_specialtyUrologymedicine.medical_treatment030232 urology & nephrologyCystectomyCystectomy03 medical and health sciences0302 clinical medicineSex FactorsInternal medicineSurveys and QuestionnairesmedicineHumansIn patientProspective StudiesPractice Patterns Physicians'AgedNeoplasm StagingChemotherapyCarcinoma Transitional Cellbusiness.industryAge FactorsCancerMultimodal therapyGuidelineMiddle Agedmedicine.diseaseSurgeryOncologyUrinary Bladder NeoplasmsCurrent practiceChemotherapy Adjuvant030220 oncology & carcinogenesisCohortFemalebusinessClinical genitourinary cancer
researchProduct

Increased Severe Adverse Outcomes and Decreased Emergency Room Visits for Pyelonephritis: First Report of Collateral Damage during COVID-19 Pandemic …

2020

<b><i>Purpose:</i></b> The coronavirus disease 2019 (COVID-19) pandemic is disrupting urology health-care worldwide. Reduced emergency room visits resulting in adverse outcomes have most recently been reported in pediatrics and cardiology. We aimed to compare patients with emergency room visits for pyelonephritis in 2019 (pre-COVID-19 era) and within the first wave of pandemic in 2020 (COVID-19 era) with regard to the number of visits and severe adverse disease outcomes. <b><i>Methods:</i></b> We performed a retrospective multicentre study comparing characteristics and outcomes of patients with pyelonephritis, excluding patients with hydroneph…

AdultMalemedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Adverse outcomesUrologymedicine.medical_treatment030232 urology & nephrologyUrologyComorbiditySide effect03 medical and health sciencesYoung Adult0302 clinical medicineInformation campaignGermanyPandemicmedicineHumansHydronephrosisPandemicsStone diseaseRetrospective StudiesOutcomePyelonephritisbusiness.industrySARS-CoV-2IncidenceCOVID-19Middle Agedmedicine.diseaseNephrectomyHospitalizationCoronavirus030220 oncology & carcinogenesis2019-nCoVCollateral damageFemaleMorbiditybusinessEmergency Service HospitalResearch ArticleUrinary infectionUrologia internationalis
researchProduct

Persistent storage symptoms after TURP can be predicted with a nomogram derived from the ice water test

2019

PURPOSE To predict the persistence of storage symptoms after transurethral resection of the prostate (TURP) using a nomogram derived from the ice water test (IWT). METHODS The IWTs of 73 men with lower urinary tract symptoms and prostatic bladder outlet obstruction were retrospectively analyzed. The strength of the detrusor contraction was approximated by using the detrusor gradient of Δpdet /Δt at maximum detrusor pressure and the area under the curve. The parameters were utilized in a nomogram, which facilitated a severity categorization from 1 to 10. Patients with a positive IWT in the categories 1 to 2 were assigned to group A, categories 3 to 4 to group B and categories 5 and higher to…

Malemedicine.medical_specialtyUrologymedicine.medical_treatmentProstatic Hyperplasia030232 urology & nephrologyUrologyurologic and male genital diseasesGroup BPersistence (computer science)03 medical and health sciencesBladder outlet obstruction0302 clinical medicineLower Urinary Tract SymptomsLower urinary tract symptomsmedicineHumansAgedRetrospective StudiesTransurethral resection of the prostateAged 80 and over030219 obstetrics & reproductive medicineUrinary Bladder Overactivebusiness.industryTransurethral Resection of ProstateArea under the curveDiagnostic Techniques UrologicalMiddle AgedNomogrammedicine.diseaseBotulinum toxinUrinary Bladder Neck ObstructionNomogramsUrodynamicsNeurology (clinical)businessmedicine.drugNeurourology and Urodynamics
researchProduct

CT-guided nephrostomy–An expedient tool for complex clinical scenarios

2018

Abstract Introduction & objectives Percutaneous nephrostomy [ 1 ] has emerged as a pivotal approach in the therapeutic management of the obstructed urinary tract. A consecutive incorporation of ultrasonic and radiographic guidance, the approach experienced an almost ubiquitious distribution while most centers currently applying either one or both of these tools jointly. However, success of ultrasound-guidance is limited in obese patients and non-dilated uropathy. In turn, fluoroscopy usually requires an opacification of the urinary collecting system by intravenous or antegrade contrast media injection, which might be harmful for already impaired renal function, raise intrapelvic pressure an…

MaleUrologic Diseasesmedicine.medical_specialtySupine positionUrinary systemmedicine.medical_treatmentKidneyRadiography Interventional030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineUrethral DiseasesmedicineHumansRadiology Nuclear Medicine and imagingObesityRenal InsufficiencyObstructive uropathyUltrasonography InterventionalAgedNephrostomy PercutaneousRetrospective Studiesbusiness.industryMortality rateGeneral MedicineOverweightmedicine.diseaseSurgeryProne positionSurgery Computer-AssistedPercutaneous nephrostomyFluoroscopy030220 oncology & carcinogenesisFeasibility StudiesFemaleMedian bodyTomography X-Ray ComputedbusinessComplicationAnesthesia LocalDilatation PathologicEuropean Journal of Radiology
researchProduct

Comparative assessment of docetaxel for safety and efficacy between hormone-sensitive and castration-resistant metastatic prostate cancer.

2019

To compare toxicity and response of docetaxel chemotherapy between metastatic hormone-sensitive prostate cancer (mHSPC) and castration-resistant metastatic prostate cancer (mCRPC) patients of the same therapeutic era for assessing of upfront docetaxel against the benchmark of docetaxel in the castrate resistant stage in the setting outside of clinical trials.A prospectively collected database of real-world prostate cancer patients receiving docetaxel was divided in mHSPC and mCRPC cases and retrospectively analyzed. Principal objectives were toxicity measured by the common criteria of adverse events terminology and response characterized by Prostate specific antigen decline and radiographic…

OncologyMalemedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsUrologymedicine.medical_treatment030232 urology & nephrologyAntineoplastic AgentsDocetaxelSeverity of Illness Index03 medical and health sciencesProstate cancer0302 clinical medicineInternal medicinemedicineHumansProspective StudiesStage (cooking)Adverse effectAgedNeoplasm StagingRetrospective StudiesChemotherapyPerformance statusbusiness.industryProstateMiddle AgedProstate-Specific Antigenmedicine.diseasePrognosisProgression-Free SurvivalClinical trialRadiographyProstate-specific antigenProstatic Neoplasms Castration-ResistantOncologyDocetaxelClinical Trials Phase III as Topic030220 oncology & carcinogenesisDisease ProgressionKallikreinsbusinessmedicine.drugUrologic oncology
researchProduct

Multimodal Deep Learning for Prognosis Prediction in Renal Cancer

2021

BackgroundClear-cell renal cell carcinoma (ccRCC) is common and associated with substantial mortality. TNM stage and histopathological grading have been the sole determinants of a patient’s prognosis for decades and there are few prognostic biomarkers used in clinical routine. Management of ccRCC involves multiple disciplines such as urology, radiology, oncology, and pathology and each of these specialties generates highly complex medical data. Here, artificial intelligence (AI) could prove extremely powerful to extract meaningful information to benefit patients.ObjectiveIn the study, we developed and evaluated a multimodal deep learning model (MMDLM) for prognosis prediction in ccRCC.Desig…

OncologyCancer ResearchPrognosis predictionmedicine.medical_specialtyrenal cancerDiseaseRenal cell carcinomaInternal medicinemedicineStage (cooking)Exome sequencingRC254-282Original Researchbusiness.industryDeep learningCancerdeep learningNeoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseartificial intelligenceradiologyOncologyCohortpathologyArtificial intelligenceprognosis predictionbusinessFrontiers in Oncology
researchProduct

Impact of preoperative risk on metastatic progression and cancer-specific mortality in patients with adverse pathology at radical prostatectomy.

2017

Objective To evaluate the impact of preoperative risk category on metastatic disease and prostate cancer-specific mortality (CSM) in patients with prostate cancer (PCa) with adverse pathology at radical prostatectomy (RP). Patients and Methods The records of 6 943 patients who underwent RP at a European tertiary centre were analysed. Biochemical recurrence (BCR), metastatic disease and CSM were assessed for patients with adverse pathology at RP, and stratified according to preoperative low- vs intermediate-/high-risk PCa groups. Kaplan–Meier, cumulative incidence, Cox regression and competing risk regression analyses were performed. Results In patients with extracapsular extension, the meta…

Biochemical recurrenceMalemedicine.medical_specialtyPathologyUrologymedicine.medical_treatment030232 urology & nephrologyUrologyKaplan-Meier EstimateLower riskCohort Studies03 medical and health sciencesProstate cancer0302 clinical medicineRisk FactorsMedicineHumansCumulative incidencePathologicalAgedProstatectomybusiness.industryProportional hazards modelProstatectomyHazard ratioProstatic NeoplasmsMiddle AgedProstate-Specific Antigenmedicine.disease030220 oncology & carcinogenesisMultivariate AnalysisbusinessBJU international
researchProduct

Nationwide analysis on the impact of socioeconomic land use factors and incidence of urothelial carcinoma

2017

Incidence rates for urothelial carcinoma (UC) have been reported to differ between countries within the European Union (EU). Besides occupational exposure to chemicals, other substances such as tobacco and nitrite in groundwater have been identified as risk factors for UC. We investigated if regional differences in UC incidence rates are associated with agricultural, industrial and residential land use.Newly diagnosed cases of UC between 2003 and 2010 were included. Information within 364 administrative districts of Germany from 2004 for land use factors were obtained and calculated as a proportion of the total area of the respective administrative district and as a smoothed proportion. Fur…

AdultMale0301 basic medicineUrologic NeoplasmsCancer ResearchMultivariate analysisAdolescentEpidemiologyYoung Adult03 medical and health sciences0302 clinical medicineRisk FactorsGermanyHumansIndustryMedicinemedia_common.cataloged_instanceYoung adultEuropean unionChildSocioeconomic statusAgedmedia_commonAged 80 and overLand usebusiness.industryIncidenceIncidence (epidemiology)SmokingAgricultureEnvironmental ExposureEnvironmental exposureMiddle Aged030104 developmental biologySocioeconomic FactorsOncologyAdministrative District030220 oncology & carcinogenesisFemalebusinessDemographyCancer Epidemiology
researchProduct

Robotic surgery can be safely performed for patients and healthcare workers during COVID‐19 pandemic

2021

OBJECTIVES: To investigate the safety of robotic surgery during COVID-19 pandemic concerning new-acquired COVID-19 infections for patients and healthcare workers. PATIENTS: We performed a retrospective single-centre cohort study of patients undergoing robotic surgery in initial period of COVID-19 pandemic. Patients and Healthcare workers COVID-19 infection status was assessed by structured telephone follow-up and/or repeated nasopharyngeal swabs. RESULTS: After 61 robotic surgeries (93,5% cancer surgery), 1 patient (1.6%) had COVID-19 infection. 60 healthcare workers cumulatively exposed to 1,187 hours of robotic surgery had no infection. One patient with postoperative proof of SARS-CoV-2 h…

Malesafetymedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Health Personnel610 MedizincoronavirusBiophysicsSARS‐CoV‐203 medical and health sciences0302 clinical medicineRobotic Surgical Procedures610 Medical sciencesHealth carePandemicmedicineHumansRobotic surgery030212 general & internal medicineElective surgeryPandemicsAgedRetrospective StudiesroboticsSARS-CoV-2business.industryCOVID-19Robotic Surgical ProceduresRetrospective cohort studyMiddle AgedinfectionComputer Science Applicationsbody regions030220 oncology & carcinogenesisEmergency medicineFemaleOriginal ArticleSurgerybusiness2019‐nCoVCohort studyThe International Journal of Medical Robotics and Computer Assisted Surgery
researchProduct

AR-V7 Protein Expression in Circulating Tumour Cells Is Not Predictive of Treatment Response in mCRPC

2019

<b><i>Introduction:</i></b> Androgen receptor variant 7 (AR-V7) plays an important role in the progression of castration-resistant prostate cancer (CRPC) and has shown potential as a predictive biomarker in circulating tumour cells (CTCs) isolated from the bloodstream in terms of a liquid biopsy. Studies have shown that AR-V7 is a potential surrogate for selecting drug classes for systemic treatment by detecting nuclear AR-V7 by immunofluorescence or measuring AR-V7 messenger RNA by quantitative PCR. Here, we assessed the predictive value of AR-V7 detected by classical immunohistochemistry (IHC) for treatment response. <b><i>Methods:</i></b> C…

MaleUrology030232 urology & nephrologyAntineoplastic AgentsDocetaxel03 medical and health scienceschemistry.chemical_compoundProstate cancer0302 clinical medicineCell Line TumormedicineHumansEnzalutamideProspective StudiesLiquid biopsyAgedAged 80 and overbusiness.industryAndrogen AntagonistsNeoplastic Cells CirculatingPrognosismedicine.diseaseAndrogen receptorProstatic Neoplasms Castration-ResistantTreatment OutcomeDocetaxelchemistryReceptors AndrogenCabazitaxel030220 oncology & carcinogenesisCancer researchBiomarker (medicine)ImmunohistochemistryTaxoidsbusinessmedicine.drugUrologia Internationalis
researchProduct

Targeting Moderate and Severe Male Stress Urinary Incontinence With Adjustable Male Slings and the Perineal Artificial Urinary Sphincter: Focus on Pe…

2017

Purpose: To analyze perioperative complications and postoperative explantation rates for selected readjustable male sling systems and the perineal single-cuff artificial urinary sphincter (AUS) in a large, contemporary, multi-institutional patient cohort. Methods: Two hundred eighty-two male patients who underwent implantation between 2010 and 2012 in 13 participating institutions were included in the study (n = 127 adjustable male sling [n = 95 Argus classic, n = 32 Argus T], n = 155 AUS). Perioperative characteristics and postoperative complications were analyzed. The explantation rates of the respective devices were assessed using the Fisher exact test and the Mann-Whitney U-test. A Kapl…

medicine.medical_specialtyIntraoperative ComplicationComplicationsUrologyUrinary Incontinence Stress030232 urology & nephrologyUrology610 Medicine & healthUrinary incontinencelcsh:RC870-923Artificial urinary sphincter03 medical and health sciencessymbols.namesake0302 clinical medicinemedicine610 Medicine & healthFisher's exact testbusiness.industryPerioperativeOdds ratiolcsh:Diseases of the genitourinary system. UrologyNeurology030220 oncology & carcinogenesisCohortsymbolsUrinary Sphincter ArtificialOriginal ArticleNeurology (clinical)medicine.symptomComplicationbusinessInternational neurourology journal
researchProduct

Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival

2016

Background Renal cell carcinoma forming a venous tumor thrombus (VTT) in the inferior vena cava (IVC) has a poor prognosis. Recent investigations have been focused on prognostic markers of survival. Thrombus consistency (TC) has been proposed to be of significant value but yet there are conflicting data. The aim of this study is to test the effect of IVC VTT consistency on cancer specific survival (CSS) in a multi-institutional cohort. Methods The records of 413 patients collected by the International Renal Cell Carcinoma–Venous Thrombus Consortium were retrospectively analyzed. All patients underwent radical nephrectomy and tumor thrombectomy. Kaplan–Meier estimate and Cox regression analy…

medicine.medical_specialtyProportional hazards modelbusiness.industrymedicine.medical_treatment030232 urology & nephrologyRetrospective cohort studyGeneral Medicinemedicine.diseaseInferior vena cavaNephrectomy03 medical and health sciences0302 clinical medicineOncologymedicine.veinRenal cell carcinoma030220 oncology & carcinogenesismedicineSurgeryRadiologyThrombusStage (cooking)businessSurvival analysisJournal of Surgical Oncology
researchProduct

Ice water test in multiple sclerosis: A pilot trial.

2018

OBJECTIVES To investigate the significance of the ice water test in patients with multiple sclerosis and to evaluate a novel ice water test nomogram in a large patient cohort. METHODS A total of 201 ice water tests of patients with multiple sclerosis were retrospectively evaluated. Incontinence episodes in 24 h and sex were correlated with the ice water test. Furthermore, an ice water test nomogram was developed in order to categorize the detrusor overactivity in severity degrees. Descriptive statistics were carried out for population characteristics. Correlations of categorical variables were calculated by the χ2 -test. The independent t-test was carried out for correlations of continuous …

AdultMalemedicine.medical_specialtyMultiple SclerosisUrologyPopulation030232 urology & nephrologyUrologyPilot Projectsurologic and male genital diseases03 medical and health sciences0302 clinical medicinemedicineHumansUrinary Bladder NeurogeniceducationFalse Negative ReactionsNeurogenic bladder dysfunctionRetrospective Studieseducation.field_of_study030219 obstetrics & reproductive medicinemedicine.diagnostic_testbusiness.industryUrinary Bladder OveractiveMultiple sclerosisIceCystometryNomogramMiddle Agedmedicine.diseaseTest (assessment)NomogramsUrodynamicsOveractive bladderCohortLinear ModelsFemalebusinesshuman activitiesInternational journal of urology : official journal of the Japanese Urological Association
researchProduct

The TiLOOP® Male Sling: Did We Forejudge.

2017

<b><i>Introduction:</i></b> To evaluate the safety and efficacy of the TiLOOP® male sling (pfm medical, Cologne, Germany) used in the treatment for male stress urinary incontinence (SUI). <b><i>Material and Methods:</i></b> We retrospectively evaluated a total of 34 patients with a TiLOOP® male sling. Perioperative complication rates were assessed and validated questionnaires were prospectively evaluated to assess quality of life and satisfaction rate. Outcome and complication rates were analysed by using descriptive statistics. Correlation of continence outcome and risk factors was performed with the chi-square test. A <i>p</i> va…

Malemedicine.medical_specialtyTime FactorsUrologic Surgical Procedures MaleUrologyUrinary Incontinence Stress030232 urology & nephrologyUrinary incontinenceProsthesis Design03 medical and health sciences0302 clinical medicinePatient satisfactionPostoperative ComplicationsQuality of lifeRisk FactorsSurveys and QuestionnairesmedicineHumansAgedRetrospective StudiesAged 80 and overSuburethral SlingsChi-Square Distributionbusiness.industryRetrospective cohort studyPerioperativeRecovery of FunctionMiddle AgedSurgeryUrodynamicsTreatment OutcomePatient Satisfaction030220 oncology & carcinogenesisCohortQuality of Lifemedicine.symptomComplicationbusinessChi-squared distributionUrologia internationalis
researchProduct

Artesunate Impairs Growth in Cisplatin-Resistant Bladder Cancer Cells by Cell Cycle Arrest, Apoptosis and Autophagy Induction

2020

Cisplatin, which induces DNA damage, is standard chemotherapy for advanced bladder cancer (BCa). However, efficacy is limited due to resistance development. Since artesunate (ART), a derivative of artemisinin originating from Traditional Chinese Medicine, has been shown to exhibit anti-tumor activity, and to inhibit DNA damage repair, the impact of artesunate on cisplatin-resistant BCa was evaluated. Cisplatin-sensitive (parental) and cisplatin-resistant BCa cells, RT4, RT112, T24, and TCCSup, were treated with ART (1&ndash

0301 basic medicineautophagyRMCell cycle checkpointDNA RepairDNA damageArtesunateCell Cycle ProteinsArticlegrowth inhibition03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCell Line TumormedicineHumansddc:610Medicine Chinese Traditionalskin and connective tissue diseaseslcsh:QH301-705.5Cell ProliferationCisplatinartesunate (ART)Cell growthAutophagyapoptosisGeneral MedicineCell cycleG1 Phase Cell Cycle Checkpoints030104 developmental biologychemistrylcsh:Biology (General)Urinary Bladder NeoplasmsApoptosisDrug Resistance Neoplasm030220 oncology & carcinogenesisCancer researchbladder cancer (BCa)Growth inhibitioncisplatin resistanceMicrotubule-Associated Proteinsmedicine.drug
researchProduct

Ruptured angiomyolipoma of the kidney: a rare differential diagnosis of flank pain.

2017

Angiomyolipomas (AMLs) of the kidney are typically benign and rare, with an incidence of 2% of all renal masses [1]. They are associated with tuberous sclerosis in about 20% of cases. If ruptured, ...

AdultMalemedicine.medical_specialtyAngiomyolipomaFlank painUrologyAngiomyolipoma030232 urology & nephrologyUreteral stoneFlank PainDiagnosis Differential03 medical and health sciencesTuberous sclerosis0302 clinical medicinemedicineHumansKidneyRupture Spontaneousbusiness.industryIncidence (epidemiology)food and beveragesmedicine.diseaseKidney NeoplasmsSurgeryTomography x ray computedmedicine.anatomical_structureNephrology030220 oncology & carcinogenesisRadiologyDifferential diagnosisbusinessTomography X-Ray ComputedScandinavian journal of urology
researchProduct

Pandemic Spread of COVID-19 Mutant Variants Will Facilitate Next-generation Sequencing Capacities for Personalised Medicine in Urologic Oncology.

2021

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySARS-CoV-2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)UrologyUrologic OncologyCOVID-19High-Throughput Nucleotide SequencingComputational biologyPrecision medicineMedical OncologyDNA sequencingPandemicMutationResearch LetterMedicineHumansPrecision MedicinebusinessEuropean urology
researchProduct

Expression of programmed death ligand-1 (PD-L1) in metastatic and postchemotherapy viable testicular germ cell tumors.

2020

Abstract Introduction Chemotherapy for testicular germ cell tumors (GCT) is highly effective, with few patients who do not respond. Clinical studies to evaluated novel treatments are challenging given the rarity of these patients. Therefore, we sought to evaluate PD-L1 staining on metastatic and postchemotherapy viable testicular GCTs as a surrogate for potential benefit for immunotherapy targeting the PD-1/PD-L1 axis. Methods Ethics research committee approval for this retrospective study was obtained by four participating institutions (CHU de Quebec, St. Joseph's Health Care, Halifax Health Science Centre, Johannes Gutenberg University). Patients with viable metastatic testicular GCTs pat…

OncologyAdultMalemedicine.medical_specialtyUrologymedicine.medical_treatment030232 urology & nephrologyB7-H1 Antigen03 medical and health sciencesYoung Adult0302 clinical medicineTesticular NeoplasmsInternal medicinemedicineHumansOrchiectomyRetrospective StudiesChemotherapybusiness.industryChoriocarcinomaRetrospective cohort studySeminomaImmunotherapyNeoplasms Germ Cell and Embryonalmedicine.diseaseOncology030220 oncology & carcinogenesisImmunohistochemistryTeratomabusinessUrologic oncology
researchProduct

Prävention im Alter durch Risikovermeidung, Früherkennung und frühe Behandlung

2019

Der wichtigste Risikofaktor fur Brustkrebs ist bei Frauen und Mannern das Alter. Brustkrebs beim Mann ist selten; Untersuchungen zur Fruherkennung werden deshalb nicht empfohlen; diese sind nur bei Veranderungen oder Beschwerden erforderlich (S3-Leitlinie Diagnostik 2018). Fur Frauen liegt das Lebenszeitrisiko fur Brustkrebs bei 12,8 %, d. h. dass jede achte Frau im Verlauf ihres Lebens an Brustkrebs erkrankt. Selten tritt Brustkrebs bei Frauen unter 30 Jahren auf. Der groste Teil der Frauen erkrankt zwischen dem 50. und 70. Lebensjahr; Mitte 60 ist das Risiko am hochsten. Etwa 37 % erkranken nach dem 70. Lebensjahr; Brustkrebs kann jedoch noch bis ins hohe Alter von 90 Jahren und mehr auft…

researchProduct

Relevance of the natural HDAC inhibitor sulforaphane as a chemopreventive agent in urologic tumors.

2018

Due to an increased understanding of molecular biology and the genomics of cancer, new and potent agents have been approved by the Food and Drug Administration (FDA) to fight this disease. However, all of these drugs cause severe side effects and resistance inevitably develops, re-activating tumor growth and dissemination. For this reason, patients turn to natural compounds as alternative or complementary treatment options, since it has been found that natural plant products may block, inhibit, or reverse cancer development. The present review focusses on the role of the natural compound sulforaphane (SFN) as an anti-tumor agent in urologic cancer. SFN is a natural compound found in crucife…

0301 basic medicineCancer ResearchUrologic NeoplasmsApoptosisDisease03 medical and health scienceschemistry.chemical_compound0302 clinical medicineIn vivoIsothiocyanatesCell Line TumorHDAC inhibitorMedicineAnticarcinogenic AgentsHumansEpigeneticsMode of actionBiological ProductsMolecular Structurebusiness.industryCruciferous vegetablesCancermedicine.diseaseHistone Deacetylase Inhibitors030104 developmental biologyOncologychemistry030220 oncology & carcinogenesisSulfoxidesBrassicaceaeCancer researchbusinessSulforaphaneCancer letters
researchProduct

Outcomes for Geriatric Urolithiasis Patients aged ≥80 Years Compared to Patients in Their Seventies

2022

Abstract Background Demographic changes are leading to an increase in geriatric urolithiasis patients aged ≥70 yr. Published data regarding their management remain sparse. In particular, for the subgroup of patients aged ≥80 yr there is a lack of evidence supporting the hypothesis that stone-removing treatment is effective, safe, and beneficial. Objective To examine the efficiency and safety of stone-removing treatment in geriatric urolithiasis patients aged ≥80 yr compared to their younger geriatric counterparts aged 70–79 yr against the background of their respective life expectancy. Design, setting, and participants Data for the study cohort were extracted from an institutional review bo…

Geriatricsmedicine.medical_specialtyPediatricsProportional hazards modelbusiness.industryUrologyUrinary systemIncidence (epidemiology)medicine.medical_treatmentConfidence intervalCohortmedicinePercutaneous nephrolithotomybusinessSurvival analysisEuropean Urology Focus
researchProduct

High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal c…

2018

Papillary renal cell carcinoma (PRCC) is currently divided in 2 subtypes. We reviewed a large cohort of PRCC and correlated subtype, morphological features and diagnostic marker expression with overall survival (OS) to uncover differences between the 2 subtypes. Three hundred seventy-six renal tumors initially diagnosed as PRCC with clinical and survival data were collected from the participating centers. Two hundred forty-six tumors were classified as PRCC1 (65.4%) and 130 as PRCC2 (34.6%) and graded according to the 2016 World Health Organization/International Society of Urological Pathology grading system. Morphological features (abundant cytoplasm, necrosis, fibrous stroma, foamy macrop…

AdultMale0301 basic medicinemedicine.medical_specialtyPathologyAdolescentPsammoma bodyPathology and Forensic MedicineMetastasisYoung Adult03 medical and health sciences0302 clinical medicineRenal cell carcinomamedicineHumansStage (cooking)ChildCarcinoma Renal CellAgedCell ProliferationNeoplasm StagingAged 80 and overTissue microarrayPapillary renal cell carcinomasbusiness.industryMiddle AgedPrognosismedicine.diseaseKidney Neoplasms030104 developmental biology030220 oncology & carcinogenesisImmunohistochemistryFemaleHistopathologybusinessHuman Pathology
researchProduct

High/low-volume center experience predicts outcome of AMS 800 in male stress incontinence: Results of a large middle European multicenter case series.

2020

AIM To analyze the influence of implantation volume of artificial sphincters (AMS 800) on outcome in a large central European multicenter cohort study. METHODS As part of the DOMINO (Debates on Male Incontinence) project, the surgical procedures and outcomes were retrospectively analyzed in a total of 473 patients who received an artificial sphincter (AMS 800) between 2010 and 2012. Clinics that implanted at least 10 AMS 800 per year were defined as high-volume centers. RESULTS Sixteen centers had a mean rate of 9.54 AMS 800/y of which five clinics were identified as high-volume centers. They implanted significantly more double cuffs (55% vs 12.1%; P < .001), used the perineal approach sign…

MaleStress incontinencemedicine.medical_specialtyUrologyUrinary Incontinence Stress030232 urology & nephrologyCohort Studies03 medical and health sciences0302 clinical medicineUrethraGermanymedicineHumansAgedRetrospective StudiesSeries (stratigraphy)030219 obstetrics & reproductive medicinebusiness.industryPerineal approachSurgical proceduresMiddle Agedmedicine.diseasePrognosisSurgeryLow volumeTreatment OutcomeAustriaCuffUrinary Sphincter ArtificialNeurology (clinical)businessCohort studyUrethral erosionNeurourology and urodynamicsREFERENCES
researchProduct

Harninkontinenz beim Mann – Ursachen, Diagnostik und Therapie

2017

Zusammenfassung. Dieser Übersichtsartikel beleuchtet den aktuellen Kenntnisstand zur Ätiologie, Diagnostik und Therapie der Harninkontinenz des Mannes. In der Ätiologie der Harninkontinenz beim Mann spielt die radikale Prostatektomie eine herausragende Rolle, aber auch das benigne Prostatasyndrom, neurologische Erkrankungen oder metabolische Störungen können zu einer Harninkontinenz beim Mann führen. In der Diagnostik ist neben der Basisdiagnostik eine qualifizierte urodynamische Beurteilung unabdingbar, um die zugrunde liegenden pathophysiologischen Mechanismen aufzudecken und Chancen und Risiken der verfügbaren Therapie- bzw. Operationstechniken abschätzen zu können. Die Primärtherapie d…

Gynecology03 medical and health sciencesmedicine.medical_specialty0302 clinical medicinebusiness.industry030220 oncology & carcinogenesisSuburethral Sling030232 urology & nephrologymedicineElectric stimulation therapyGeneral MedicinebusinessArtificial sphincterPraxis
researchProduct

The timing of initial imaging in testicular cancer: impact on radiological findings and clinical decision making

2021

Background In testicular cancer determination of clinical stage and recommendation of therapeutic strategy after inguinal orchiectomy are based on primary imaging by CT-scan of the chest and CT- or MRI- abdomen. It has not been investigated so far, whether the imaging should be performed before or after primary testicular surgery. Staging before surgery means exposing all patients to CT radiation irrespective of ensured histologic malignancy while postoperative staging could pose a risk in biased clinical decision making by increased presence of unspecific lymph node enlargement caused by postsurgical effects. Therefore, we aimed to investigate the association between the timing of initial …

2748 UrologyMalemedicine.medical_specialtyUrologymedicine.medical_treatmentClinical Decision-Making610 Medicine & health2700 General MedicineMalignancyTesticular NeoplasmsmedicineHumansStage (cooking)Lymph nodeTesticular cancerNeoplasm StagingRetrospective StudiesInguinal orchiectomy2727 Nephrology10042 Clinic for Diagnostic and Interventional Radiologybusiness.industrymedicine.diseasemedicine.anatomical_structureNephrologyLymphatic MetastasisRadiological weaponCohortAbdomenRadiologybusinessMinerva Urology and Nephrology
researchProduct

Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Nov…

2017

Abstract Darolutamide (ODM-201) is a novel androgen receptor (AR) antagonist with a chemical structure distinctly different from currently approved AR antagonists that targets both wild-type and mutated ligand binding domain variants to inhibit AR nuclear translocation. Here, we evaluate the activity of darolutamide in enzalutamide-resistant castration resistant prostate cancer (CRPC) as well as in AR mutants detected in patients after treatment with enzalutamide, abiraterone, or bicalutamide. Darolutamide significantly inhibited cell growth and AR transcriptional activity in enzalutamide-resistant MR49F cells in vitro, and led to decreased tumor volume and serum prostate-specific antigen l…

0301 basic medicineMaleModels MolecularTime FactorsTranscription GeneticProtein ConformationProstate cancerchemistry.chemical_compoundMice0302 clinical medicineMolecular Targeted TherapyTumor BurdenDarolutamideReceptors Androgen030220 oncology & carcinogenesisBenzamidesmedicine.drugSignal Transductionmedicine.medical_specialtyBicalutamideUrologyPartial agonist03 medical and health sciencesStructure-Activity RelationshipIn vivoInternal medicineCell Line TumorNitrilesPhenylthiohydantoinmedicineAndrogen Receptor AntagonistsEnzalutamideAnimalsHumansCell ProliferationDose-Response Relationship DrugCell growthbusiness.industryProstatic Neoplasmsmedicine.diseaseXenograft Model Antitumor AssaysAndrogen receptor030104 developmental biologyEndocrinologychemistryDrug Resistance NeoplasmMutationCancer researchPyrazolesbusinessEuropean urology
researchProduct

What should be the patient&amp;#39;s preference regarding the choice of hospital in the case of radical cystectomy? Evaluation of early complications…

2016

Jens Mani,1 Stefan Vallo,1&amp;nbsp;Maximilian P Brandt,1 Kilian M Gust,1 Claudia Bartsch,1 Johannes Daechert,1 Igor Tsaur,1 Georg Bartsch,2,* Axel Haferkamp1,* 1Department of Urology, Goethe University Hospital, Frankfurt am Main, 2Department of Urology, Johannes Gutenberg University Hospital Mainz, Mainz, Germany *These authors contributed equally to this work Purpose: This study compares early complications after cystectomy and urinary diversion (UD) stratified by the surgical focus and case load of two different department chairpersons in a single institution in two time periods. Creating clear data about complications that can affect the quality of life is an important tool for patient…

medicine.medical_specialtyClavien-Dindo Classificationbusiness.industryHealth Policymedicine.medical_treatmentSignificant differenceUrinary diversion030232 urology & nephrologyMedicine (miscellaneous)University hospitalSurgeryCystectomy03 medical and health sciences0302 clinical medicineVolume settingQuality of lifePatient Preference and Adherence030220 oncology & carcinogenesisMedicinebusinessComplicationPharmacology Toxicology and Pharmaceutics (miscellaneous)Social Sciences (miscellaneous)Patient Preference and Adherence
researchProduct

SARS-CoV-2 outbreak in medical employees in a large urologic department: Spread, containment and outcome.

2021

Background The SARS-CoV-2 pandemic presents an unprecedented challenge to health care systems worldwide. Data on SARS-CoV-2 transmission in a hospital is rare and outbreaks among health care professionals are complex to control. Material and Methods Over the course of 6 consecutive weeks we recorded data on an exponential outbreak of SARS-CoV-2 within our department. We reconstructed the assumed route of the spread of infection, and the employees’ acute and late symptoms. Increasing preventive measures (mandatory face masks, intense training in hygiene, physical distancing whenever possible, and termination of visits from outside the hospital) were implemented. Results Within 6 weeks, 13 em…

medicine.medical_specialtyEpidemiologymedia_common.quotation_subjectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Health PersonnelDisease Outbreaks03 medical and health sciences0302 clinical medicineHygienePandemicHealth careMajor ArticleMedicineHumans030212 general & internal medicinePandemicsmedia_common0303 health sciencesViral spreadPandemic030306 microbiologybusiness.industryTransmission (medicine)Medical settingSARS-CoV-2Health PolicyPublic Health Environmental and Occupational HealthOutbreakCOVID-19Face masksInfectious DiseasesEmergency medicinebusinessAmerican journal of infection control
researchProduct

A Nomogram to Characterize the Severity of Detrusor Overactivity during the Ice Water Test: Description of the Method and Proof of Concept

2017

&lt;b&gt;&lt;i&gt;Aims:&lt;/i&gt;&lt;/b&gt; To develop a nomogram with severity categories for detrusor overactivity (DO). &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; By conducting ice water tests (IWT) in 55 patients with Parkinson’s disease, we identified criteria to describe characteristics of the detrusor pressure curves: (1) a gradient of Δ&lt;i&gt;pdet&lt;/i&gt; over Δt at the maximum detrusor pressure and (2) the area under the curve. In a nomogram, 10 severity categories of DO were established: 1 and 2 were assigned to group A (mild), 3 and 4 to group B (moderate) and 5–10 to group C (severe). &lt;b&gt;&lt;i&gt;Results:&lt;/i&gt;&lt;/b&gt; In the nomogram, negative IWT (20) appea…

Malemedicine.medical_specialtygenetic structuresUrologyUrinary Bladder030232 urology & nephrologyUrologyurologic and male genital diseasesProof of Concept Study03 medical and health sciences0302 clinical medicinemedicineHumansUrinary Bladder NeurogenicAgedUrinary Bladder Overactivebusiness.industryArea under the curveReproducibility of ResultsParkinson DiseaseMiddle AgedNomogramIce waterNomogramsUrodynamicsAdministration IntravesicalUrinary Incontinence030220 oncology & carcinogenesisDetrusor pressureFemalebusinessUrologia Internationalis
researchProduct

ASSOCIATION OF AN ORGAN TRANSPLANT-BASED APPROACH WITH A DRAMATIC REDUCTION IN POSTOPERATIVE COMPLICATIONS FOLLOWING RADICAL NEPHRECTOMY AND TUMOR TH…

2019

Objectives: Our aim was to determine whether using an organ transplant-based(TB) approach reduces postoperative complications(PCs) following radical nephrectomy(RN) and tumor thrombectomy(TT) in renal cell carcinoma(RCC) patients with level II-IV thrombi. Methods: A total of 390(292 non-TB/98 TB) IRCC-VT Consortium patients who received no preoperative embolization/IVC filter were included. Stepwise linear/logistic regression analyses were performed to determine significant multivariable predictors of intraoperative estimated blood loss(IEBL), number blood transfusions received, and overall/major PC development within 30days following surgery. Propensity to receive the TB approach was contr…

MaleKidney DiseaseVena Cavamedicine.medical_treatment030232 urology & nephrologyLogistic regressionNephrectomyOrgan transplantation0302 clinical medicinePostoperative ComplicationsRenal cell carcinomaInferior vena cavaCancerThrombectomyGeneral MedicineMiddle AgedNephrectomyRenal cell carcinomaKidney NeoplasmsOncologymedicine.vein030220 oncology & carcinogenesisFemaleInferior vena cava; Postoperative complications; Renal cell carcinoma; Surgical technique; Tumor thrombus6.4 SurgeryInferiormedicine.medical_specialtyOncology and CarcinogenesisUrologyIvc filterVena Cava InferiorInferior vena cavaArticle03 medical and health sciencesPostoperative complicationsRare DiseasesBlood lossmedicineHumansBlood TransfusionOncology & CarcinogenesisCarcinoma Renal CellRetrospective Studiesbusiness.industryCarcinomaRenal CellEvaluation of treatments and therapeutic interventionsSurgical techniqueThrombosismedicine.diseasePostoperative complicationTumor thrombusPropensity score matchingSurgerybusinessFollow-Up Studies
researchProduct

Risk Factors for Failure of Male Slings and Artificial Urinary Sphincters: Results from a Large Middle European Cohort Study.

2016

&lt;b&gt;&lt;i&gt;Introduction:&lt;/i&gt;&lt;/b&gt; We analysed the impact of predefined risk factors: age, diabetes, history of pelvic irradiation, prior surgery for stress urinary incontinence (SUI), prior urethral stricture, additional procedure during SUI surgery, duration of incontinence, ASA-classification and cause for incontinence on failure and complications in male SUI surgery. &lt;b&gt;&lt;i&gt;Materials and Methods:&lt;/i&gt;&lt;/b&gt; We retrospectively identified 506 patients with an artificial urinary sphincter (AUS) and 513 patients with a male sling (MS) in a multicenter cohort study. Complication rates were correlated to the risk factors in univariate analysis. Subsequentl…

Malemedicine.medical_specialtyTime FactorsUrologic Surgical Procedures MaleUrethral strictureUrologyUrinary Incontinence Stress030232 urology & nephrologyUrologyUrinary incontinenceKaplan-Meier EstimateProsthesis DesignDisease-Free SurvivalArtificial urinary sphincter03 medical and health sciences0302 clinical medicineRisk FactorsmedicineOdds RatioHumansTreatment FailureRisk factorAgedRetrospective StudiesUnivariate analysisSuburethral SlingsChi-Square Distributionbusiness.industryRetrospective cohort studyOdds ratioMiddle Agedmedicine.diseaseProsthesis FailureEuropeLogistic Models030220 oncology & carcinogenesisMultivariate AnalysisUrinary Sphincter Artificialmedicine.symptombusinessCohort studyUrologia internationalis
researchProduct

Artificial Urinary Sphincter Cuff Size Predicts Outcome in Male Patients Treated for Stress Incontinence: Results of a Large Central European Multice…

2019

Purpose The aim was to study the correlation between cuff size and outcome after implantation of an AMS 800 artificial urinary sphincter. Methods A total of 473 male patients with an AMS 800 sphincter implanted between 2012 and 2014 were analyzed in a retrospective multicenter cohort study performed as part of the Central European Debates on Male Incontinence (DOMINO) Project. Results Single cuffs were implanted in 54.5% and double cuffs in 45.5% of the patients. The cuffs used had a median circumference of 4.5 cm. Within a median follow of 18 months, urethral erosion occurred in 12.8% of the cases and was associated significantly more often with small cuff sizes (P<0.001). Multivariate ana…

Malemedicine.medical_specialtyStress incontinenceUrologySingle or double cuff030232 urology & nephrologylcsh:RC870-923Erosion rateArtificial urinary sphincter03 medical and health sciences0302 clinical medicineMedicineClinical InvestigationRisk factorAMS 800030219 obstetrics & reproductive medicineStress urinary incontinencebusiness.industryArtificial urinary sphincterlcsh:Diseases of the genitourinary system. Urologymedicine.diseaseCuff sizeSurgerymedicine.anatomical_structureNeurologyMale patientCuffSphincterOriginal ArticleNeurology (clinical)businessCohort studyInternational Neurourology Journal
researchProduct

sE-cadherin is upregulated in serum of patients with renal cell carcinoma and promotes tumor cell dissemination in vitro

2019

Abstract Introduction Cadherin family proteins are involved in the tumorigenesis of several malignancies. However, their significance in renal cell carcinoma (RCC) has not been extensively investigated. The current study investigates the potential of several cadherins to perform as biomarkers for tumor detection and exert functional RCC activity. Methods Pre- and postoperative concentrations of sE-cadherin, cadherin-6, N-cadherin, cadherin-11, cadherin-17, and cadherin-5 were measured in serum of patients undergoing surgery for RCC and correlated to clinical and histopathological parameters. Control serum was obtained from healthy volunteers. A498 and Caki-1 cells were incubated with sE-cad…

AdultMaleUrologyPopulation030232 urology & nephrologymedicine.disease_cause03 medical and health sciences0302 clinical medicineDownregulation and upregulationRenal cell carcinomaBiomarkers TumorTumor Cells CulturedmedicineHumansNeoplasm InvasivenessProspective StudieseducationCarcinoma Renal CellAgedAged 80 and overeducation.field_of_studyCadherinCell growthbusiness.industryChemotaxisMiddle AgedCadherinsmedicine.diseaseKidney NeoplasmsUp-RegulationOncology030220 oncology & carcinogenesisCancer cellCancer researchFemaleCarcinogenesisbusinessUrologic Oncology: Seminars and Original Investigations
researchProduct

Increased tumor vascularization is associated with the amount of immune competent PD‑1 positive cells in testicular germ cell tumors

2018

Testicular germ cell cancer in a metastatic state is curable with a cisplatin‑based first line chemotherapy. However, 10‑15% of these patients are resistant to first line chemotherapy and are thus left with only palliative options. Immunotherapies and inhibition of angiogenesis used in multiple types of cancer; however, the molecular context of angiogenesis and immune checkpoints in the development and progression of testicular cancers is still unknown. Therefore, the present study performed tissue micro array based analysis of 84 patients with immunohistochemistry of programmed cell death protein 1 (PD‑1), programmed cell death ligand 1 (PD‑L1) and vascular endothelial growth factor recept…

0301 basic medicineendocrine systemCancer ResearchOncogeneAngiogenesisbusiness.industrymedicine.medical_treatmentCancerImmunotherapyCell cyclemedicine.disease03 medical and health sciences030104 developmental biology0302 clinical medicineImmune systemOncology030220 oncology & carcinogenesismedicineCancer researchCytotoxic T cellddc:610businessTesticular cancerOncology Letters
researchProduct

Abstract 6327: Artesunate reduces tumor growth and induces different kinds of cell death in docetaxel-resistant prostate carcinoma cells

2020

Abstract Introduction: Prostate carcinoma (PCa) is the most common cancer in men. The therapeutic effect of approved compounds, such as docetaxel, is limited due to the development of therapy resistance, making new treatment options essential. Artesunate (ART), used in Traditional Chinese Medicine, has shown anti-tumor activity in several tumor types. However, little is known about the efficacy of ART on therapy-resistant PCa. Therefore, the impact of ART on docetaxel-resistant PCa cells was investigated. Material and Methods: Parental (=sensitive) and docetaxel-resistant PCa cell lines, PC3, DU145, and LNCaP, were exposed to ART [1-100 µM] for 24, 48, or 72 hours. Cells not exposed to ART …

Cancer ResearchCell cycle checkpointbusiness.industryCellCancerCell cycleurologic and male genital diseasesmedicine.diseaseProstate cancermedicine.anatomical_structureOncologyDU145ApoptosisLNCaPmedicineCancer researchbusinessCancer Research
researchProduct

Incidence, Risk Factors and Management of Symptomatic Lymphoceles after Radical Retropubic Prostatectomy

2017

Abstract Introduction We investigated the incidence, clinical course and risk factors for symptomatic lymphoceles after radical retropubic prostatectomy with pelvic lymph node dissection. Moreover, we explored parameters for the failure of percutaneous lymphocele drainage. Methods The incidence of symptomatic lymphoceles in patients with prostate cancer who underwent radical retropubic prostatectomy with pelvic lymph node dissection in our department between 2008 and 2013 was investigated retrospectively. The occurrence of lymphoceles was correlated with several clinical and histopathological parameters. In addition, logistic regression analysis was performed to assess the value of independ…

medicine.medical_specialtyPercutaneousbusiness.industryProstatectomyUrologymedicine.medical_treatment030232 urology & nephrologymedicine.diseaseSurgery03 medical and health sciencesDissectionLymphocele0302 clinical medicinemedicine.anatomical_structure030220 oncology & carcinogenesismedicineLymphRisk factorbusinessLymph nodeRadical retropubic prostatectomyUrology Practice
researchProduct

Die bipolare Stimulation kann die Erfolgsrate des Peripheren Nervenevaluationstests der sakralen Neuromodulation verbessern

2017

Zusammenfassung Fragestellung Die vorliegende Studie vergleicht die unipolare und die bipolare Stimulationstechnik während des Peripheren Nervenevaluationstestes der Sakralen Neuromodulation in einer Kohorte von 100 Patienten mit nicht-neurogenen und neurogenen Harntraktfunktionsstörungen und überprüft die Hypothese, dass die bipolare Technik der unipolaren bezogen auf die Testeffektivität überlegen ist. Material und Methoden In diese Fall-Kontroll-Studie wurden 43 Patienten mit biopolarer und 57 Patienten mit unipolarer Stimulation eingeschlossen. Für die bipolare Stimulation wurden vier Elektroden an S3 und S4 beidseits platziert und die Elektroden von S3 und S4 jeder Seite elektrisch ver…

Gynecology03 medical and health sciencesmedicine.medical_specialty030219 obstetrics & reproductive medicine0302 clinical medicineSacral nerve stimulationbusiness.industryUrology030232 urology & nephrologyMedicinebusinessBipolar stimulationAktuelle Urologie
researchProduct

Artesunate Inhibits Growth of Sunitinib-Resistant Renal Cell Carcinoma Cells through Cell Cycle Arrest and Induction of Ferroptosis

2020

Although innovative therapeutic concepts have led to better treatment of advanced renal cell carcinoma (RCC), efficacy is still limited due to the tumor developing resistance to applied drugs. Artesunate (ART) has demonstrated anti-tumor effects in different tumor entities. This study was designed to investigate the impact of ART (1&ndash

0301 basic medicineCancer ResearchTraditional Chinese Medicine (TCM) growth inhibition ferroptosis reactive oxygen species (ROS)Cell cycle checkpointBiologyurologic and male genital diseasesreactive oxygen species (ROS)lcsh:RC254-282Articlegrowth inhibition03 medical and health scienceschemistry.chemical_compound0302 clinical medicinerenal cell carcinoma (RCC)medicineClonogenic assayCytotoxicityartesunate (ART)SunitinibTraditional Chinese Medicine (TCM)Cell cyclelcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensferroptosissunitib resistance030104 developmental biologyOncologychemistryCell cultureApoptosis030220 oncology & carcinogenesisCancer researchGrowth inhibitionmedicine.drugCancers
researchProduct

Fixed or adjustable sling in the treatment of male stress urinary incontinence: results from a large cohort study

2020

BACKGROUND: Fixed and adjustable male slings for the treatment of male urinary stress incontinence became increasingly popular during the last decade. Although fixed slings are recommended for the treatment of mild to moderate stress urinary incontinence, there is still a lack of evidence regarding the precise indication for an adjustable male sling. Furthermore, there is still no evidence that one type of male sling is superior to another. However, both, adjustable and fixed slings, are commonly utilized in daily clinical practice. This current investigation aims to evaluate the differences between fixed and adjustable male slings regarding indications, complication rates and functional ou…

medicine.medical_specialtyUrethral stricturebusiness.industryUrologyMedical recordUrinary incontinencemedicine.diseaseLarge cohortSling (weapon)Surgeryddc:03 medical and health sciences0302 clinical medicineReproductive MedicineQuality of life030220 oncology & carcinogenesisCohortmedicineOriginal Articlemedicine.symptomComplicationbusiness030217 neurology & neurosurgery
researchProduct

Antibiotic Coating of the Artificial Urinary Sphincter (AMS 800): Is it Worthwhile?

2016

Objective To investigate the impact of the antibiotic coating InhibiZone on the infection and explantation rates of the AMS 800 in comparison to the AMS 800 without InhibiZone. Materials and Methods We retrospectively identified 305 patients with an AMS 800 in a multicenter cohort study. Patients were subsequently divided into InhibiZone and without InhibiZone-coated groups. Infection and explantation rates were analyzed by univariate and consecutively by multivariate logistic regression adjusted to variable risk factors. The infection-free interval was estimated by Kaplan-Meier plot and compared by the log-rank test. A P value below .05 was considered statistically significant. Results We …

Malemedicine.medical_specialtyProsthesis-Related InfectionsMultivariate analysismedicine.drug_classUrologyAntibiotics030232 urology & nephrologyLong Term Adverse EffectsProsthesis DesignLogistic regressionRisk AssessmentGastroenterologyCohort StudiesArtificial urinary sphincter03 medical and health sciences0302 clinical medicineCoated Materials BiocompatibleRisk FactorsInternal medicineOutcome Assessment Health CaremedicineHumansAgedUnivariate analysisbusiness.industrySignificant differenceMiddle AgedAnti-Bacterial AgentsSurgeryUrinary Incontinence030220 oncology & carcinogenesisUrinary Tract InfectionsCohortUrinary Sphincter ArtificialFemalebusinessCohort studyUrology
researchProduct

Prognostic Factors of Papillary Renal Cell Carcinoma: Results From a Multi-Institutional Series After Pathological Review

2009

We examined papillary renal cell carcinoma prognostic variables and validated the 2002 UICC TNM staging system in a multicenter analysis.From 10 urological institutions in Germany followup data were collected on a total of 675 patients with papillary renal cell carcinoma. Central pathological review was done to validate external histopathological diagnoses. The Kaplan-Meier method was used to derive cumulative cancer specific and overall survival, and the log rank test was used to compare the curves of 2 or more groups. For multivariate analysis of prognostic factors Cox regression analysis was done. All proportional hazard assumptions were systemically verified using the Grambsch-Therneau …

MaleOncologymedicine.medical_specialtyPathologyPrognostic variableUrologyTNM staging systemRenal cell carcinomaInternal medicinemedicineCarcinomaHumansCarcinoma Renal CellNeoplasm StagingRetrospective StudiesPapillary renal cell carcinomasProportional hazards modelbusiness.industryCancerMiddle AgedPrognosismedicine.diseaseKidney NeoplasmsSurvival RateLog-rank testFemalebusinessJournal of Urology
researchProduct

Antimicrobial Lubricant Did Not Reduce Infection Rate in Transrectal Biopsy Patients in a Large Randomized Trial Due to Low Complication Rates

2018

Abstract Background Transrectal prostate biopsy (pbx) is the most frequent outpatient procedure in the urological field. Septic complications are a major health issue. Objective To evaluate complication rates with or without an antimicrobial lubricant. Design, setting, and participants A total of 1000 patients received pbx between 2013 and 2015. Information about complications was collected by a 3-wk questionnaire. Return rate was 73.2% (n = 732). Intervention Randomization for pbx with the instillation of an antimicrobial lubricant (intervention group, n = 385) or the standard lubricant (control group, n = 347) was performed. Outcome measurements and statistical analysis Multivariable anal…

Image-Guided BiopsyMalemedicine.medical_specialtyProstate biopsyFeverUrology030232 urology & nephrologyPatient ReadmissionHematospermialaw.invention03 medical and health sciencesPostoperative Complications0302 clinical medicineRandomized controlled triallawGermanyInternal medicineBiopsymedicineHumansProspective StudiesAgedHematuriaLubricantsmedicine.diagnostic_testbusiness.industryUrinary retentionProstateRectumProstatic NeoplasmsAntibiotic ProphylaxisHemospermiaUrinary RetentionAnti-Bacterial AgentsTransrectal biopsy030220 oncology & carcinogenesisInternational Prostate Symptom Scoremedicine.symptomGastrointestinal HemorrhageComplicationbusinessEuropean Urology Focus
researchProduct

Phase 2 of the Coronavirus Pandemic in Urology: Ramping Up Surgical Caseload and Resident Training while COVID-19 Infections Decrease

2021

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industryUrologyResident trainingSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)medicine.disease_causeEmergency medicinePandemicMedicineClinical competencebusinessLetter to the EditorCoronavirusUrologia Internationalis
researchProduct

The impact of perioperative complications on favorable outcomes after artificial urinary sphincter implantation for post-prostatectomy incontinence

2020

ABSTRACT Objective To investigate the effect of perioperative complications involving artificial urinary sphincter (AUS) implantation on rates of explantation and continence as well as health-related quality of life (HRQOL). Materials and methods Inclusion criteria encompassed non-neurogenic, moderate-to-severe stress urinary incontinence (SUI) post radical prostatectomy and primary implantation of an AUS performed by a high-volume surgeon (>100 previous implantations). Reporting complications followed the validated Clavien-Dindo scale and Martin criteria. HRQOL was assessed by the validated IQOL score, continence by the validated ICIQ-SF score. Statistical analysis included Chi (2) test, M…

medicine.medical_specialtyMultivariate analysisVisual analogue scaleUrinary Incontinence StressUrologymedicine.medical_treatmentUrinary system030232 urology & nephrologyUrinary incontinencelcsh:RC870-923Artificial urinary sphincter03 medical and health sciences0302 clinical medicineurinary sphincter artificialQuality of lifeMedicinebusiness.industryProstatectomyPerioperativelcsh:Diseases of the genitourinary system. UrologySurgeryquality of life030220 oncology & carcinogenesisQuality of LifeUrinary Sphincter Artificialmedicine.symptomurinary incontinence stressbusinessInternational braz j urol
researchProduct

Cost-effectiveness analysis of robot-assisted vs. open partial nephrectomy

2017

Background The cost-effectiveness of robot-assisted partial nephrectomy (RAPN) vs. the open procedure is not established. Methods We estimated in-hospital complications and the cost of RAPN vs. open partial nephrectomy (OPN) using an economic model. Costs incurred both intraoperatively and in hospital were considered. US data were extracted from existing literature. Results Mean in-hospital costs were $14,824 (95% CI $13,368-$16,898) for RAPN and $15,094 (95% CI $13,491-$17,140) for OPN. Complications after RAPN occurred in 23.3% (95% CI 20.0-25.8%) and after OPN in 36.1% (95% CI 35.6-36.6%) of the patients. In a sensitivity analysis, limited centre experience was associated with relevant i…

medicine.medical_specialtyCost-Benefit Analysismedicine.medical_treatment030232 urology & nephrologyBiophysicsNephrectomy03 medical and health sciencesPostoperative Complications0302 clinical medicineRobotic Surgical ProceduresmedicineHumansOpen partial nephrectomyHospital CostsComputer-assisted surgerybusiness.industryDecision TreesPerioperativeCost-effectiveness analysisNephrectomyComputer Science ApplicationsSurgeryModels EconomicTreatment Outcome030220 oncology & carcinogenesisSurgeryLower costbusinessThe International Journal of Medical Robotics and Computer Assisted Surgery
researchProduct

The impact of perioperative complications on favorable outcomes after artificial urinary sphincter implantation for post-prostatectomy incontinence

2021

ABSTRACT Objective To investigate the effect of perioperative complications involving artificial urinary sphincter (AUS) implantation on rates of explantation and continence as well as health-related quality of life (HRQOL). Materials and methods Inclusion criteria encompassed non-neurogenic, moderate-to-severe stress urinary incontinence (SUI) post radical prostatectomy and primary implantation of an AUS performed by a high-volume surgeon (&gt;100 previous implantations). Reporting complications followed the validated Clavien-Dindo scale and Martin criteria. HRQOL was assessed by the validated IQOL score, continence by the validated ICIQ-SF score. Statistical analysis included Chi (2) test…

researchProduct